Isda’s Korean OTC law criticism

South Korea’s New Product Approval bill passed its first stage on February 16. The bill has been strongly opposed by Isda. Here are its concerns in full

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree